Home
>
National Drug Code (NDC)
>
Aptivus
Aptivus - 0597-0002-01 - (tipranavir)
Drug Information of Aptivus
| Product NDC: | 0597-0002 |
| Proprietary Name: | Aptivus |
| Non Proprietary Name: | tipranavir |
| Active Ingredient(s): | 100 mg/mL & nbsp; tipranavir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Aptivus
| Product NDC: | 0597-0002 |
| Labeler Name: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022292 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080901 |
Package Information of Aptivus
| Package NDC: | 0597-0002-01 |
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (0597-0002-01) > 95 mL in 1 BOTTLE, GLASS |
NDC Information of Aptivus
| NDC Code | 0597-0002-01 |
| Proprietary Name | Aptivus |
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (0597-0002-01) > 95 mL in 1 BOTTLE, GLASS |
| Product NDC | 0597-0002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tipranavir |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20080901 |
| Marketing Category Name | NDA |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | TIPRANAVIR |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
